ArkeaBio is an ag-biotech start-up developing a safe, user-friendly, and cost-conscious vaccine to reduce ruminant methane emissions that will work seamlessly with existing global agribusiness practices. With a record of success and a growing reputation in the industry, ArkeaBio has emerged as a leading player known for its cutting-edge solutions, ground-breaking research, and unwavering commitment to changing the sustainable agricultural landscape as we know it.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/09/24 | $26,500,000 | Series A |
AgriZeroNZ Breakthrough Energy Ventures  Grantham Foundation Overview Capital Rabo Ventures The51 Food & AgTech Fund | undisclosed |
